Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Potential of darusentan in CHF, hypertension supported by clinical trial results

Sep. 7, 2001

Pharmacyclics reports interim phase I results for Antrin photoangioplasty for CAD

Sep. 7, 2001

Important new information on heart failure now available from Prous Science

Sep. 7, 2001

Long-term outcome in patients with severe PH receiving continuous s.c. UT-15

Sep. 7, 2001

Vasogen receives clearance to begin pivotal clinical trial of PAD treatment

Sep. 6, 2001

TNF overproduction attenuated by testosterone in blood from CHF patients

Sep. 6, 2001

Beneficial effects of allopurinol on peripheral blood flow in CHF

Sep. 6, 2001

Calcium sensitizers may be useful for enhancing myocardial contractile function in septic shock

Sep. 6, 2001

Ivabradine exerts selective bradycardic effects in exercised dogs

Sep. 6, 2001

FDA approves Medtronic's InSync cardiac resynchronization therapy device

Sep. 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026